Comparison of Sodium–Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide Receptor Agonists for Atrial Fibrillation in Type 2 Diabetes Mellitus: Systematic Review With Network Meta-analysis of Randomized Controlled Trials

医学 内科学 利西塞纳泰德 相对风险 2型糖尿病 2型糖尿病 荟萃分析 糖尿病 利拉鲁肽 随机对照试验 心房颤动 内分泌学 安慰剂 置信区间 病理 替代医学
作者
Wenjie Li,Xingqing Chen,Xiangqi Xie,Min Xu,Lingling Xu,Peiying Liu,Bihui Luo
出处
期刊:Journal of Cardiovascular Pharmacology [Lippincott Williams & Wilkins]
卷期号:79 (3): 281-288 被引量:40
标识
DOI:10.1097/fjc.0000000000001197
摘要

ABSTRACT: Atrial fibrillation (AF) is a major public health concern with a rising prevalence. Although sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown the respective favorable effects on reducing the occurrence of AF/atrial flutter (AFL), comparative protective AF/AFL effects between above 2 novel antidiabetic agents remain unavailable. Thus, we aimed to evaluate the comparative efficacy of SGLT2is and GLP-1RAs in reducing the risk of AF/AFL in patients with type 2 diabetes and estimate relative rankings of interventions. PubMed, Embase, and ClinicalTrials.gov were searched up to December 1, 2020. All available randomized controlled trials comparing SGLT2is and GLP-1RAs with one another or placebo in patients with type 2 diabetes were included. Pooled results were shown as risk ratios (RRs) with 95% confidence intervals (CIs). We used a frequentist network meta-analysis to evaluate the outcomes of interests. Thirty-six randomized controlled trials including 85,701 participants with type 2 diabetes were identified. Compared with placebo, both SGLT2is (RR: 0.82, 95% CI, 0.68-0.99) and GLP-1RAs (RR: 0.86, 95% CI, 0.76-0.97; RR long-acting ones: 0.87, 95% CI, 0.76-0.99; RR short-acting ones: 0.72, 95% CI, 0.45-1.14) significantly reduced AF/AFL risk. No significant difference between SGLT2is and GLP-1RAs was noted (RR: 0.95, 95% CI, 0.76-1.2). Compared with placebo, results from the analysis showed an RR of 0.72 (95% CI, 0.45-1.14) for short-acting GLP-1RAs and 0.87 (95% CI, 0.76-0.99) for long-acting GLP-1RAs in reducing the risk of AF/AFL. Compared with placebo, both SGLT2is and GLP-1RAs possessed favorable effects on reducing the risk of AF/AFL. However, no difference was observed when comparisons were made between them. In addition, long-acting ones may confer a more pronounced AF/AFL reduction benefit compared with placebo.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
香蕉觅云的应助被milai采纳,获得10
刚刚
1秒前
1秒前
1秒前
Eli发布了新的文献求助10
2秒前
Owen的应助被xhj采纳,获得10
2秒前
4秒前
wangxkk完成签到,获得积分10
4秒前
彪壮的半莲完成签到,获得积分10
5秒前
yyy完成签到,获得积分10
5秒前
ma发布了新的文献求助10
5秒前
5秒前
6秒前
rrrr完成签到,获得积分10
6秒前
6秒前
平若颜发布了新的文献求助10
7秒前
多买一只表完成签到 ,获得积分10
7秒前
dugu0010完成签到,获得积分10
7秒前
9秒前
Lucas的应助被1111采纳,获得10
11秒前
hhhhhh完成签到,获得积分20
11秒前
爆米花的应助被故里采纳,获得10
12秒前
ping发布了新的文献求助30
12秒前
eas完成签到,获得积分10
13秒前
orixero的应助被动人的仙人掌采纳,获得10
13秒前
14秒前
15秒前
15秒前
lit发布了新的文献求助50
15秒前
许愿的应助被番薯区丧彪采纳,获得10
15秒前
xinxin发布了新的文献求助20
16秒前
17秒前
17秒前
17秒前
18秒前
小星星发布了新的文献求助10
18秒前
菠菜的应助被feather采纳,获得10
18秒前
ykyk0927完成签到 ,获得积分10
19秒前
20秒前
wumting完成签到 ,获得积分20
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163664
求助须知:如何正确求助?哪些是违规求助? 9557817
关于积分的说明 21741980
捐赠科研通 7754358
什么是DOI,文献DOI怎么找? 3428338
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472943